ID
40988
Beschrijving
The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitis Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias
Trefwoorden
Versies (1)
- 07-06-20 07-06-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
7 juni 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin
Pharmacodynamics - (mOGTT - Blood) V8 9-DF
- StudyEvent: ODM
Beschrijving
10 minutes pre-glucose
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
Pre-glucose
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
10 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
20 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
30 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
60 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
90 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
120 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Beschrijving
180 minutes post
Alias
- UMLS CUI-1
- C0040223
- UMLS CUI-2
- C0200345
- UMLS CUI-3
- C0017725
Similar models
Pharmacodynamics - (mOGTT - Blood) V8 9-DF
- StudyEvent: ODM
C0808070 (UMLS CUI-2)
C1301880 (UMLS CUI-3)
C0017725 (UMLS CUI-4)
C0017725 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI-2)
C0017725 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])